Companies Dominating the Antimicrobial Regenerative Wound Matrix Landscape
- 3M Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Turn Therapeutics
- Dsm Biomedical
- H&R healthcare Ltd
- Harbor Medtech Inc
- Smith and Nephew plc
- Aroa Biosurgery Ltd
- Renovoderm Integra
- Organogenesis Inc.
- Integra Lifesciences Holdings Corporation
Browse Key Market Insights with Data Illustration:
In the News
- A leading regenerative medicine company Organogenesis Inc. in order to note the wound care, surgical and sports medicine-related landscape the company intending on the development, manufacture and commercialize of products, announced the availability of a new, easy-to-use, 1.6 cm disc size of its PuraPly antimicrobial wound management product.
- Integra Lifesciences Holdings Corporation, announces that it is preparing to bring OmnigraftTM Dermal Rejuvenating Matrix onto the market pending receipt of definitive approval by the US Food and Drug Administration.
